Evdokia Anagnostou

Last updated

Evdokia Anagnostou is a Canadian pediatric neurologist. She is a professor in the Department of Pediatrics at the University of Toronto, and is cross-appointed as pediatric neurologist and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. She is a Tier 2 Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder.

Contents

Career

Anagnostou is currently a professor in the Department of Pediatrics at the University of Toronto, and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. [1] [2] Her research focuses on translating findings from basic research studies in the field of Autism Spectrum Disorder and related neurodevelopmental conditions into novel therapeutics. Upon realizing that patients with Autism Spectrum Disorder often have additional disorders (including intellectual disability, ADHD and OCD), Anagnostou and her colleagues launched the Province of Ontario Neurodevelopmental Disorders (POND) Network in 2013 to study multiple neurodevelopmental disorders (including Autism Spectrum Disorder) together. [3] She is a principal investigator at POND, funded by the Ontario Brain Institute. [3] [4] POND co-investigators include Stephen W. Scherer. [4]

Anagnostou was appointed as the inaugural Dr. Stuart D. Sims Chair in Autism at the Holland Bloorview Kids Rehabilitation Hospital in December 2016, and co-leads the Autism Research Centre within the institution. [5] [6] She was also appointed as a Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder in November 2017. [7] She is an associate editor for Molecular Autism and Autism Research, and a grant reviewer for multiple international agencies

Anagnostou's research has been cited over 23,000 times and has an h-index of 71. [8] She regularly comments on Autism Spectrum Disorder as an expert on various Canadian media platforms. [9] [10] [11] [12] [13]

Selected bibliography

Honours and awards

References

  1. ↑ "Scientists - Bloorview Research Institute". research.hollandbloorview.ca. Retrieved 2019-02-11.[ permanent dead link ]
  2. ↑ "Evdokia Anagnostou |". ims.utoronto.ca. Retrieved 2019-02-11.
  3. 1 2 "ADHD, OCD, autism: Is it time to redraw the boundaries separating childhood behavioural disorders?" . Retrieved 2019-02-11.
  4. 1 2 Children, The Hospital for Sick. "Province of Ontario Neurodevelopmental Disorders (POND)". sickkids.ca. Retrieved 2019-02-11.
  5. 1 2 Shephard, Tamara (2016-12-15). "Holland Bloorview appoints inaugural autism chair". Toronto.com. Retrieved 2019-02-11.
  6. 1 2 "Anagnostou Named Holland Bloorview Inaugural Autism Chair". hollandbloorview.ca. Retrieved 2019-02-11.
  7. 1 2 Government of Canada, Industry Canada (2012-11-29). "Canada Research Chairs". chairs-chaires.gc.ca. Retrieved 2019-02-11.
  8. ↑ "evdokia anagnostou - Google Scholar Citations". Google Scholar. Retrieved 2024-08-01.
  9. ↑ Irel, Nicole. "Treatment to remove metals from children with autism unproven and risky, but no clear regulations". Canadian Broadcasting Corporation. Retrieved 2019-02-11.
  10. ↑ "Study suggests link between DDT exposure and autism risk". www.ctvnews.ca. 16 August 2018. Retrieved 2019-02-11.
  11. ↑ "The myths and misconceptions of Autism". Breakfast Television Toronto. Retrieved 2019-02-11.
  12. ↑ "Mom with daughter living with autism says there's still a stigma that needs quashing". Canadian Broadcasting Corporation. Retrieved 2019-02-11.
  13. ↑ "Autism in adults: Why are so few treatments available?". www.ctvnews.ca. 27 April 2016. Retrieved 2019-02-11.
  14. ↑ Hollander, Eric; Anagnostou, Evdokia; Chaplin, William; Esposito, Katherine; Haznedar, M. Mehmet; Licalzi, Elizabeth; Wasserman, Stacey; Soorya, Latha; Buchsbaum, Monte (2005-08-01). "Striatal Volume on Magnetic Resonance Imaging and Repetitive Behaviors in Autism". Biological Psychiatry. 58 (3): 226–232. doi:10.1016/j.biopsych.2005.03.040. ISSN   0006-3223. PMID   15939406. S2CID   28829114.
  15. ↑ Hollander, Eric; Bartz, Jennifer; Chaplin, William; Phillips, Ann; Sumner, Jennifer; Soorya, Latha; Anagnostou, Evdokia; Wasserman, Stacey (2007-02-15). "Oxytocin Increases Retention of Social Cognition in Autism". Biological Psychiatry. Advances in Understanding and Treating Autism Spectrum Disorders. 61 (4): 498–503. doi:10.1016/j.biopsych.2006.05.030. ISSN   0006-3223. PMID   16904652. S2CID   46560.
  16. ↑ Ritz, Louise; Wagner, Ann; Hirtz, Deborah; Sullivan, Lisa; Dukes, Kimberly; Anagnostou, Evdokia; Donnelly, Craig L.; Bregman, Joel D.; Scahill, Lawrence (2009-06-01). "Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior: Citalopram Ineffective in Children With Autism". Archives of General Psychiatry. 66 (6): 583–590. doi:10.1001/archgenpsychiatry.2009.30. ISSN   0003-990X. PMC   4112556 . PMID   19487623.
  17. ↑ Hakonarson, Hakon; Schellenberg, Gerard D.; Devlin, Bernie; Buxbaum, Joseph D.; Cook, Edwin H.; Bucan, Maja; Grant, Struan F. A.; Minshew, Nancy J.; Sutcliffe, James S. (May 2009). "Autism genome-wide copy number variation reveals ubiquitin and neuronal genes". Nature. 459 (7246): 569–573. Bibcode:2009Natur.459..569G. doi:10.1038/nature07953. ISSN   1476-4687. PMC   2925224 . PMID   19404257.
  18. ↑ Pinto, Dalila; Delaby, Elsa; Merico, Daniele; Barbosa, Mafalda; Merikangas, Alison; Klei, Lambertus; Thiruvahindrapuram, Bhooma; Xu, Xiao; Ziman, Robert (2014-05-01). "Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders". The American Journal of Human Genetics. 94 (5): 677–694. doi:10.1016/j.ajhg.2014.03.018. ISSN   0002-9297. PMC   4067558 . PMID   24768552.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.